Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Hydroxypropyl Beta Cyclodextrin
2. 2 Hydroxypropyl-beta-cyclodextrin
3. 2-hydroxypropyl-beta-cyclodextrin
4. Beta Hydroxypropylcyclodextrin
5. Beta-hydroxypropylcyclodextrin
6. Betadex, Hydroxypropyl
7. Hp-beta-cd
8. Hpbetacd
9. Hydroxypropyl Beta Cyclodextrin
10. Hydroxypropyl Betadex
11. Hydroxypropyl-beta-cyclodextrin
1. 107745-73-3
2. Hp-beta-cd
3. 2-hydroxypropyl-
4. A-cyclodextrin
5. 6a,6b,6c,6d,6e,6f,6g-heptakis-o-(2-hydroxypropyl)-beta-cyclodextrin
6. Trappsol Hpb
7. Hydroxypropylbetadex
8. Thpb
9. Hydroxypropyl-beta-cyclodextri
10. Hydroxypropyl-beta Cyclodextrin
11. Chembl577294
12. Dtxsid401017375
13. .beta.-cyclodextrin, 6a,6b,6c,6d,6e,6f,6g-heptakis-o-(2-hydroxypropyl)-
14. 6a,6b,6c,6d,6e,6f,6g-heptakis-o-(2-hydroxypropyl)-beta-cyclodextrinr
Molecular Weight | 1541.5 g/mol |
---|---|
Molecular Formula | C63H112O42 |
XLogP3 | -13 |
Hydrogen Bond Donor Count | 21 |
Hydrogen Bond Acceptor Count | 42 |
Rotatable Bond Count | 28 |
Exact Mass | 1540.6628176 g/mol |
Monoisotopic Mass | 1540.6628176 g/mol |
Topological Polar Surface Area | 619 Ų |
Heavy Atom Count | 105 |
Formal Charge | 0 |
Complexity | 2010 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 35 |
Undefined Atom Stereocenter Count | 7 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Excipients
Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. (See all compounds classified as Excipients.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?